Nov 22 TG Therapeutics Inc :
* TG Therapeutics announces positive DSMB recommendation for continuation of the UNITY-CLL phase 3 trial
* Still targeting completion of enrollment in first half of 2018
* TG Therapeutics announces positive DSMB recommendation for continuation of the UNITY-CLL phase 3 trial Source text for Eikon: Further company coverage:
One dead in ENI Congo oil platform fire
BRAZZAVILLE, Dec 3 One person was killed in a fire on an oil platform operated by ENI Congo off the coast of the Congo Republic city of Pointe-Noire, the government said.
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.